/THE SCIENCE

What’s
actually
in here.

No hype. No vague hand-waving. A primer on peptides, sublingual delivery, and why we built the strip — for athletes who read the studies, not just the labels.

/01 · PRIMER

A peptide is a signal, not a stimulant.

Peptides are short chains of amino acids — typically 2 to 50 residues long. They sit between single amino acids and full proteins on the size scale, and they are the primary language the body uses to send signals between cells.

Insulin is a peptide. Oxytocin is a peptide. The hormones that tell your tissues to grow, repair, or burn fuel — peptides. Athletes don’t need a chemistry degree to know peptides matter; they need to know which signals support recovery and how to deliver them reliably.

That’s the entire job of the Soovi catalog. Each compound is a signal. Each strip is a delivery vehicle. Each daily dose is a small cumulative push toward your output ceiling.

“”The body already speaks peptide. We’re just helping you say the right things at the right volume.””

— Dr. R. Mehta · Reverra Health · Scientific Director

LAB / SCIENTIST
PHOTOGRAPHY
/02 · DELIVERY

Three roads. One doesn’t suck.

Every peptide is only as good as its delivery system. Bioavailability — the share of the active compound that actually reaches your bloodstream — is the variable nobody markets but everybody should compare.

/01

Oral capsule

Most peptides do not survive the stomach. Acidic environment + digestive enzymes = a fraction of the dose ever reaches circulation.

Bioavailability~5–15%
Onset45+ min
FrictionLow
/02

Subcutaneous injection

High bioavailability — but introduces sterility risk, sharps disposal, refrigeration, travel headaches, and a daily lifestyle compromise.

Bioavailability~95%+
Onset15–30 min
FrictionVery high
/03 · MECHANISM · BPC-157

Where BPC-157 actually acts.

BPC stands for Body Protective Compound. It is a synthetic 15-amino-acid peptide derived from a sequence found in human gastric juice — a fragment of a larger naturally-occurring protein that the body produces to protect its own tissues.

The compound has been studied for its role in angiogenesis (the formation of new blood vessels), fibroblast migration (the cells that lay down new connective tissue), and nitric-oxide pathway modulation — all three of which are core to how tendon, ligament, and muscle structures rebuild after mechanical stress.

Translation: BPC-157 doesn’t make you stronger today. It supports the underlying machinery that turns today’s training into tomorrow’s adaptation.

Tendon and ligament tissues are poorly vascularized. That’s why they take so long to heal. BPC-157’s role in angiogenesis is exactly why it shows up in athlete protocols.

This is also why consistency beats intensity. One dose does almost nothing. Thirty doses, one a day, every day, for a month — that’s the protocol shape that matches the underlying biology.

It is also why we built the strip. Every gram of friction you remove from a daily protocol is a gram of biological output you keep.

/04 · THE ARC

What 30 days looks like.

A general arc reported by the athletes we’ve onboarded. Individual response varies — biology is not on rails.

Week 01 · Days 1–7

Onset

The protocol starts. No dramatic shift, by design — peptide signals work cumulatively. The win at this stage is operational: you actually take it daily, the strip removes the friction, the routine sticks.

Week 02 · Days 8–14

Subtle signal

Most athletes report the first noticeable change in the second week — slightly faster recovery from a hard session, slightly less morning stiffness, or a long-standing nagging spot starting to feel less aggravated.

Week 03 · Days 15–21

Cumulative effect

The compounding starts to show. Daily training output stabilizes. The recovery window between sessions tightens. This is typically when athletes commit to subscribe — they’ve felt the signal.

Week 04 · Days 22–30

Renewal

Strip 30 dissolves. Pack 2 ships. The protocol re-runs. With Subscribe & Save, this transition happens with zero attention — the way a well-designed protocol should run.

/05 · LITERATURE

Selected references.

A short, public-domain bibliography. Full references and additional studies are available on request via support@soovi.com.

[01]

BPC-157 and tendon healing — preclinical evidence
Sikiric et al. · J. Orthop. Surg. Res. · 2018
[02]

Sublingual peptide delivery — bioavailability review
Drug Deliv. Translat. Res. · 2021
[03]

Pullulan film carriers in pharmaceutical applications
Carbohydr. Polym. · 2020
[04]

Angiogenic effects of BPC-157 in vascular models
Curr. Pharm. Des. · 2019
[05]

Connective-tissue recovery & athlete training load
Sports Med. · 2020
[06]

First-pass metabolism in oral peptide delivery
Eur. J. Pharm. Biopharm. · 2017

Disclaimer. The content on this page is for informational and educational purposes only and is not intended as medical advice. Statements regarding peptide compounds have not been evaluated by the FDA. The Soovi catalog is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before beginning any supplementation protocol.